I

IX Biopharma Ltd
SGX:42C

Watchlist Manager
IX Biopharma Ltd
SGX:42C
Watchlist
Price: 0.114 SGD 0.88% Market Closed
Market Cap: 109m SGD

Wall Street
Price Targets

42C Price Targets Summary
IX Biopharma Ltd

There are no price targets for 42C.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
IX Biopharma Ltd Competitors:
Price Targets
CRON
Cronos Group Inc
38% Upside
GLAXO
GlaxoSmithKline Pharmaceuticals Ltd
20% Upside
2096
Simcere Pharmaceutical Group Ltd
20% Upside
300558
Betta Pharmaceuticals Co Ltd
35% Upside
4547
Kissei Pharmaceutical Co Ltd
9% Upside
AGY
Allergy Therapeutics PLC
24% Upside
VETO
Vetoquinol SA
20% Upside

Revenue
Forecast

Revenue Estimate
IX Biopharma Ltd

The compound annual growth rate of IX Biopharma Ltd's revenue for the next 1 year is 50%.

N/A
Past Growth
50%
Estimated Growth
Estimates Accuracy
2%
Average Beat

Operating Income
Forecast

Operating Income Estimate
IX Biopharma Ltd

Operating Income forecast
is not available for
IX Biopharma Ltd

Net Income
Forecast

Net Income Estimate
IX Biopharma Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-21%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is 42C's stock price target?
Not Available

42C doesn't have any price targets made by Wall Street professionals.

What is IX Biopharma Ltd's Revenue forecast?
Projected CAGR
50%

The compound annual growth rate of IX Biopharma Ltd's revenue for the next 1 year is 50%.

Back to Top